{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:20:59Z","timestamp":1790468459359,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH","award":["NS065917"],"award-info":[{"award-number":["NS065917"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.brainres.2010.06.059","type":"journal-article","created":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T04:53:36Z","timestamp":1277960016000},"page":"208-213","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["Intravenous treatment of experimental Parkinson's disease in the mouse with an IgG-GDNF fusion protein that penetrates the blood\u2013brain barrier"],"prefix":"10.1016","volume":"1352","author":[{"given":"Ailing","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Hui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric Ka-Wai","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff Zhiqiang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben J.","family":"Boado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William M.","family":"Pardridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2010.06.059_bb0005","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.bbr.2007.01.028","article-title":"Repetitive vibrissae-elicited forelimb placing before and immediately after unilateral 6-hydroxydopamine improves outcome in a model of Parkinson's disease","volume":"179","author":"Anstrom","year":"2007","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainres.2010.06.059_bb0010","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0306-4522(01)00268-8","article-title":"Stroke induces widespread changes of gene expression for glial cell line-derived neurotrophic factor family receptors in the adult rat brain","volume":"106","author":"Arvidsson","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2010.06.059_bb0015","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1124\/dmd.109.028787","article-title":"Comparison of blood\u2013brain barrier transport of glial-derived neurotrophic factor (GDNF) and an IgG-GDNF fusion protein in the rhesus monkey","volume":"37","author":"Boado","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.brainres.2010.06.059_bb0020","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/bit.21764","article-title":"GDNF fusion protein for targeted-drug delivery across the human blood\u2013brain barrier","volume":"100","author":"Boado","year":"2008","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.brainres.2010.06.059_bb0025","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/bit.22135","article-title":"Engineering and expression of a chimeric transferrin receptor monoclonal antibody for blood\u2013brain barrier delivery in the mouse","volume":"102","author":"Boado","year":"2009","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.brainres.2010.06.059_bb0030","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.neulet.2008.04.089","article-title":"Time-course of GDNF and its receptor expression after brain injury in the rat","volume":"439","author":"Cheng","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2010.06.059_bb0035","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1097\/00001756-199807130-00039","article-title":"GDNF administration induces recovery of the nigrostriatal dopaminergic system both in young and aged parkinsonian mice","volume":"9","author":"Date","year":"1998","journal-title":"NeuroReport"},{"key":"10.1016\/j.brainres.2010.06.059_bb0040","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1182\/blood-2008-02-138073","article-title":"Activation of natural regulatory T cells by IgG Fc-derived peptide \"Tregitopes\"","volume":"112","author":"De Groot","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.brainres.2010.06.059_bb0045","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.brainres.2006.01.083","article-title":"Application of a blood\u2013brain-barrier-penetrating form of GDNF in a mouse model for Parkinson's disease","volume":"1082","author":"Dietz","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2010.06.059_bb0050","doi-asserted-by":"crossref","first-page":"5901","DOI":"10.1093\/emboj\/18.21.5901","article-title":"Distinct structural elements in GDNF mediate binding to GFRalpha1 and activation of the GFRalpha1-c-Ret receptor complex","volume":"18","author":"Eketjall","year":"1999","journal-title":"EMBO J."},{"key":"10.1016\/j.brainres.2010.06.059_bb0055","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0304-3940(94)90218-6","article-title":"Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo","volume":"182","author":"Hoffer","year":"1994","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2010.06.059_bb0060","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0304-3940(03)00007-7","article-title":"Glial cell line-derived neurotrophic factor does not enter normal mouse brain","volume":"340","author":"Kastin","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2010.06.059_bb0065","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/ana.20737","article-title":"Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease","volume":"59","author":"Lang","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.brainres.2010.06.059_bb0070","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0306-4522(97)83045-X","article-title":"Glial cell line-derived neurotrophic factor attenuates behavioural deficits and regulates nigrostriatal dopaminergic and peptidergic markers in 6-hydroxydopamine-lesioned adult rats: comparison of intraventricular and intranigral delivery","volume":"78","author":"Lapchak","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2010.06.059_bb0075","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0022-3565(24)35388-1","article-title":"Targeting rat anti-mouse transferrin receptor monoclonal antibodies through the blood\u2013brain barrier in the mouse","volume":"292","author":"Lee","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainres.2010.06.059_bb0080","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1021\/bc0155061","article-title":"Pharmacokinetics and delivery of tat and tat-protein conjugates to tissues in vivo","volume":"12","author":"Lee","year":"2001","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.brainres.2010.06.059_bb0085","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.nbd.2004.01.007","article-title":"A model of L-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function","volume":"16","author":"Lundblad","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.brainres.2010.06.059_bb0090","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0896-6273(02)01054-1","article-title":"Drug and gene delivery to the brain: the vascular route","volume":"36","author":"Pardridge","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.brainres.2010.06.059_bb0095","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3109\/10611860903548354","article-title":"Biopharmaceutical drug targeting to the brain","volume":"18","author":"Pardridge","year":"2010","journal-title":"J. Drug Target."},{"key":"10.1016\/j.brainres.2010.06.059_bb0100","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1007\/s11095-009-9939-6","article-title":"Pharmacokinetics and safety in rhesus monkeys of a monoclonal antibody-GDNF fusion protein for targeted blood\u2013brain barrier delivery","volume":"26","author":"Pardridge","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.brainres.2010.06.059_bb0105","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1023\/A:1016244500596","article-title":"Human insulin receptor monoclonal antibody undergoes high affinity binding to human brain capillaries in vitro and rapid transcytosis through the blood\u2013brain barrier in vivo in the primate","volume":"12","author":"Pardridge","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/j.brainres.2010.06.059_bb0110","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.expneurol.2006.07.015","article-title":"Point source concentration of GDNF may explain failure of phase II clinical trial","volume":"202","author":"Salvatore","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainres.2010.06.059_bb0115","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1046\/j.1471-4159.2002.00993.x","article-title":"Glial cell line-derived neurotrophic factor up-regulates the expression of tyrosine hydroxylase gene in human neuroblastoma cell lines","volume":"82","author":"Xiao","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2010.06.059_bb0120","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10735-006-9035-8","article-title":"Distribution of GDNF family receptor alpha3 and RET in rat and human non-neural tissues","volume":"37","author":"Yang","year":"2006","journal-title":"J. Mol. Histol."},{"key":"10.1016\/j.brainres.2010.06.059_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/10430340360464660","article-title":"Intravenous nonviral gene therapy causes normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism","volume":"14","author":"Zhang","year":"2003","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.brainres.2010.06.059_bb0130","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1124\/dmd.109.031534","article-title":"Monoclonal antibody-glial-derived neurotrophic factor fusion protein penetrates the blood\u2013brain barrier in the mouse","volume":"38","author":"Zhou","year":"2010","journal-title":"Drug Metab. Dispos."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899310014514?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899310014514?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T07:44:35Z","timestamp":1740210275000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899310014514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":26,"alternative-id":["S0006899310014514"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2010.06.059","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}